| scholarly article | Q13442814 |
| P50 | author | Jukka Hartikka | Q37835185 |
| P2093 | author name string | Wheeler CJ | |
| Margalith M | |||
| Hazard D | |||
| Sawdey M | |||
| Nishioka WK | |||
| Sukhu L | |||
| Bozoukova V | |||
| Buchner C | |||
| Manthorp M | |||
| P433 | issue | 5 | |
| P921 | main subject | electroporation | Q1142521 |
| P304 | page(s) | 407-415 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. | |
| P478 | volume | 4 |
| Q92588885 | A Critical Review of Electroporation as A Plasmid Delivery System in Mouse Skeletal Muscle |
| Q57094261 | A Review of DNA Vaccines Against Influenza |
| Q33199034 | A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle |
| Q40585842 | Biodegradable triblock copolymer of PLGA-PEG-PLGA enhances gene transfection efficiency |
| Q44390690 | Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice. |
| Q45855631 | Comparing reagents for efficient transfection of human primary myoblasts: FuGENE 6, Effectene and ExGen 500. |
| Q35616420 | Competitive electroporation formulation for cell therapy |
| Q44541945 | Efficient in vitro and in vivo expression of covalently modified plasmid DNA. |
| Q79614711 | Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity |
| Q37238941 | Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle |
| Q30476834 | Electroporation advances in large animals |
| Q24793340 | Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells |
| Q37744992 | Electroporation for DNA immunization: clinical application |
| Q36981658 | Electroporation-based DNA immunisation: translation to the clinic |
| Q36070120 | Electroporation-mediated gene transfer directly to the swine heart |
| Q50528235 | Enhanced gene transduction into skeletal muscle of mice in vivo with pluronic block copolymers and ultrasound exposure. |
| Q47839469 | Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. |
| Q34784634 | Gene electro transfer of plasmid encoding vascular endothelial growth factor for enhanced expression and perfusion in the ischemic swine heart |
| Q33324150 | Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression |
| Q39310355 | Gene electrotransfer: from biophysical mechanisms to in vivo applications : Part 2 - In vivo developments and present clinical applications |
| Q45130728 | Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscle |
| Q33289258 | Gene expression profiles in skeletal muscle after gene electrotransfer |
| Q74577437 | High-efficiency gene electrotransfer into skeletal muscle: description and physiological applicability of a new pulse generator |
| Q44178360 | Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle |
| Q30988980 | In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle |
| Q39644871 | In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization |
| Q37547141 | In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses |
| Q35012898 | In vivo plasmid DNA electrotransfer |
| Q97539209 | Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics |
| Q45883168 | Insonation facilitates plasmid DNA transfection into the central nervous system and microbubbles enhance the effect |
| Q78524512 | Interleukin-10 expression after intramuscular DNA electrotransfer: kinetic studies |
| Q60342834 | Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts |
| Q28652428 | Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells |
| Q33285443 | Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. |
| Q45864162 | Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design |
| Q45882295 | Multiparametric functional nuclear magnetic resonance imaging shows alterations associated with plasmid electrotransfer in mouse skeletal muscle |
| Q54377731 | Muscle Damage After Delivery of Naked Plasmid DNA into Skeletal Muscles Is Batch Dependent |
| Q35108230 | Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. |
| Q38028448 | Nonviral gene therapy targeting cardiovascular system |
| Q34521794 | Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. |
| Q35583526 | Optimal modes and targets of gene therapy in transplantation |
| Q50540694 | P85, Optison microbubbles and ultrasound cooperate in mediating plasmid DNA transfection in mouse skeletal muscles in vivo. |
| Q55423022 | PEO-PPO-PEO Tri-Block Copolymers for Gene Delivery Applications in Human Regenerative Medicine-An Overview. |
| Q35543245 | Physiological and histological changes in skeletal muscle following in vivo gene transfer by electroporation |
| Q34311495 | Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas |
| Q36704473 | Plasmid-based gene therapy of diabetes mellitus |
| Q64378310 | Pluronic Block Copolymers for Gene Delivery |
| Q36293316 | Pluronic block copolymers for gene delivery. |
| Q35754353 | Polymer genomics: an insight into pharmacology and toxicology of nanomedicines |
| Q35079580 | Progress and prospects: naked DNA gene transfer and therapy |
| Q36889718 | Quantitative real-time PCR study on persistence of pDNA vaccine pVax-Hsp60 TM814 in beef muscles |
| Q36803909 | Radionuclide reporter gene imaging for cardiac gene therapy |
| Q73507070 | Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity |
| Q45863794 | Safe and efficient local gene delivery into skeletal muscle via a combination of Pluronic L64 and modified electrotransfer |
| Q40226824 | Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation |
| Q38313032 | Supramolecular design of biocompatible nanocontainers based on amphiphilic derivatives of a natural compound isosteviol |
| Q37155956 | The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells |
| Q36549699 | Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy. |
| Q37530540 | Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers |
| Q40366702 | Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells. |
| Q45861363 | Variability of naked DNA expression after direct local injection: the influence of the injection speed |
| Q35826665 | Vector Design for Improved DNA Vaccine Efficacy, Safety and Production |
Search more.